119th Congress
H.R. 8000
END 7-OH Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Gus M. Bilirakis(R-FL)
- Introduced
- Mar 19, 2026
- Policy area
- Crime and Law Enforcement
- Committees
- House Committee on Energy and Commerce; House Committee on the Judiciary
- Official text
- Introduced in House · Congress.gov page
Cosponsors (9)
Added later (9)
- Laurel M. Lee (R-FL) · Mar 20, 2026
- Vern Buchanan (R-FL) · Mar 25, 2026
- Lance Gooden (R-TX) · Aug 13, 2026
- Darin LaHood (R-IL) · Sep 16, 2026
- Mark B. Messmer (R-IN) · Sep 16, 2026
- Mike Haridopolos (R-FL) · Sep 16, 2026
- Richard McCormick (R-GA) · Sep 16, 2026
- Stephanie I. Bice (R-OK) · Sep 16, 2026
- Mike Kelly (R-PA) · Sep 28, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To amend the Controlled Substances Act to schedule synthetic 7-hydroxymitragynine as a Schedule I controlled substance.
Latest action(Mar 19, 2026): Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Roll-call votes
No recorded votes on this bill.
Actions
- Mar 19, 2026 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - Mar 19, 2026
Introduced in House